Germline RUNX1 mutations cause RUNX1 familial platelet disorder (RUNX1-FPD), which is characterized by thrombocytopenia, autoimmune diseases, and increased risk for MDS and AML, with an average age (in years) of onset in the mid-30s (6–8). Here, RUNX1 is linked to Thrombocytopenia.